H.R. 4242 — Orphan Drug Innovation Act

Summary

Orphan Drug Innovation Act - Amends the Federal Food, Drug and Cosmetic Act, with respect to orphan drugs, to provide for the waiver of the seven-year prohibition against approval for a drug which is clinically superior to an approved drug.

Full Text

Legislative Actions

2000-04-11
Introduced in House
2000-04-11
Introduced in House
2000-04-11
Referred to the House Committee on Commerce.
2000-04-24
Referred to the Subcommittee on Health and Environment.

Orphan Drug Innovation Act

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill